Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHACTR3 antisense RNA 1 (PHACTR3-AS1) is putatively a long non-coding RNA gene annotated antisense to the PHACTR3 locus. By convention, "antisense RNAs" are non-coding RNA genes that are transcribed from the opposite strand of a protein-coding gene and may potentially regulate gene expression through RNA interference, epigenetic modulation, or RNA-DNA/RNA interaction mechanisms[6]. However, the specific molecule PHACTR3-AS1 has no direct experimental evidence, reported biological functions, disease associations, or drug interactions in available biomedical literature and databases. Its annotation is based on genomic mapping and convention rather than functional or clinical research. If you need structured data for PHACTR3 (the protein-coding gene "Phosphatase and actin regulator 3"), extensive molecular and functional information is available[1][4][5][7]. In contrast, PHACTR3-AS1 remains uncharacterized and is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHACTR3 antisense RNA 1 (PHACTR3-AS1).